Andrew Concoff, MD, FACR, is the chief medical officer and chair of the Medical Policy Committee for Specialty Networks/United Rheumatology, where he designs and implements real-world evidence projects and negotiates value-based care arrangements on behalf of rheumatologists with health plans and pharmaceutical manufacturers.
References
- Mannion ML, Xie F, FitzGerald JD, et al. Changes in the workforce characteristics of providers who care for adult patients with rheumatologic and musculoskeletal disease in the United States. Arthritis Rheumatol. 2024;76(7):1153–1161.
- Battafarano DF, Ditmyer M, Bolster MB, et al. 2015 American College of Rheumatology workforce study: Supply and demand projections of adult rheumatology workforce, 2015–2030. Arthritis Care Res (Hoboken). 2018 Apr;70(4):617–626.
- Dinse GE, Parks CG, Weinberg CR, et al. Increasing prevalence of antinuclear antibodies in the United States. Arthritis Rheumatol. 2022 Dec;74(12):2032–2041.
- Duarte-Garcia A, Hocaoglu M, Valenzuela-Almada M, et al. The rising incidence and prevalence of systemic lupus erythematosus. A population-based study over four decades. Ann Rheum Dis. 2022 Aug;81(9):1260–1266.
- GBD 2021 Rheumatoid Arthritis Collaborators. Global, regional, and national burden of rheumatoid arthritis, 1990–2020, and projections to 2050: A systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol. 2023 Sep;5(10):e594–e610.
- The Physicians Foundation. 2024 survey of America’s current and future physicians. 2024 Jul. https://physiciansfoundation.org/wp-content/uploads/2024-Survey-of-Americas-Current-and-Future-Physicians.pdf.
- Lee YC, Lu F, Colls J, et al. Outcomes of a mobile app to monitor patient-reported outcomes in rheumatoid arthritis: A randomized controlled trial. Arthritis Rheumatol. 2021 Aug;73(8):1421–1429.
- Colls J, Corrigan C, Suh D, et al. Patient adherence with a smartphone app for rheumatoid arthritis. Ann Rheum Dis. 2019;78:350–351.
- Solomon DH, Altwies H, Santacroce L, et al. A mobile health application integrated in the electronic health record for rheumatoid arthritis patient-reported outcomes: A controlled interrupted time-series analysis of impact on visit efficiency. Arthritis Rheumatol. 2024 May;76:677–683.
- Seppen B, Wiegel J, Ter Wee MM, et al. Smartphone-assisted patient-initiated care versus usual care in patients with rheumatoid arthritis and low disease activity: A randomized controlled trial. Arthritis Rheumatol. 2022 Nov;74(11):1737–1745.
- Berg IJ, Tveter AT, Bakland G, et al. Follow-up of patients with axial spondyloarthritis in specialist health care with remote monitoring and self-monitoring compared with regular face-to-face follow-up visits (the ReMonit study): Protocol for a randomized, controlled open-label noninferiority trial. JMIR Res Protoc. 2023 Dec;12:e52872.
- Olsen NJ, Karp DR. Finding lupus in the ANA haystack. Lupus Sci Med. 2020 Feb;7(1): e000384.
- Slater CA, Davis RB, Shmerling RH. Antinuclear antibody testing. A study of clinical utility. Arch Intern Med. 1996 Jul;156(13):1421–1425.
- Qaseem A, Alguire P, Dallas P, et al. Appropriate use of screening and diagnostic tests to foster high-value, cost-conscious care. Ann Intern Med. 2012 Jan;156(2):147–149.
- Yazdany J, Schmajuk G, Robbins M, et al. Choosing wisely: The American College of Rheumatology’s top 5 list of things physicians and patients should question. Arthritis Care Res. 2013 Mar;65(3):329–339.
- Jack C, Hazel E, Bernatsky S. Something’s missing here: A look at the quality of rheumatology referral letters. Rheumatol Int. 2012 Apr;32(4):1083–1085.
- Wong J, Tu K, Bernatsky S, et al. Quality and continuity of information between primary care physicians and rheumatologists. BMC Rheumatol. 2019 May:3:1.
- Barnado A, Moore RP, Domenico HJ, et al. Identifying antinuclear antibody positive individuals at risk for developing systemic autoimmune disease: Development and validation of a real-time risk model. Front Immunol. 2024 Mar 20:15:1384229.
- Fitch-Rogalsky C, Steber W, Mahler M, et al. Clinical and serological features of patients referred through a rheumatology triage system because of positive antinuclear antibodies. PLoS ONE. 2014 Apr;9(4): e93812.
- Girman C, Panaccio MP, Hayes K, et al. Pain and fatigue improvements in patients treated with repository corticotropin injection across five indications: A narrative review. Adv Ther. 2022 Jul;39(7):3072–3087.
- Germain G, Worley K, MacKnight SD, et al. Evaluating the real-world effectiveness of belimumab in patients with SLE using SLE- related laboratory values and rheumatoid arthritis-derived disease activity measures: RAPID3, swollen joint count and tender joint count. Lupus Sci Med. 2024 Apr 3;11(1):e001111.
- Eudy AM, Reeve BB, Coles T, et al. The use of patient-reported outcome measures to classify type 1 and 2 systemic lupus erythematosus activity. Lupus. 2022 May; 31(6):697–705.
- Brkic A, Losinska K, Pripp A-H, et al. Remission or not remission, that’s the question: Shedding light on remission and the impact of objective and subjective measures reflecting disease activity in rheumatoid arthritis. Rheumatol Ther. 2022 Dec;9(6):1531–1547.
- Boone NW, Sepriano A, van der Kuy P-H, et al. Routine assessment of patient index data 3 (RAPID3) alone is insufficient to monitor disease activity in rheumatoid arthritis in clinical practice. RMD Open. 2019 Nov;5(2):e001050.
- Duarte C, Ferreira RJO, Santos EJF, et al. Treating-to-target in rheumatology: Theory and practice. Best Pract Res Clin Rheumatol. 2022 Mar;36(1):101735.
- Binder-Fineman P, Dzurilla K, Hsiao B, Fraenkel L. Qualitative exploration of triangulated, shared decision-making in rheumatoid arthritis. Arthritis Care Res. 2019 Dec;71(12):1576–1582.
- Solomon DH, Rudin RS. Digital health technologies: Opportunities and challenges in rheumatology. Nat Rev Rheumatol. 2020 Sep;16(9):525–535.
Disclosures
Dr. Solomon serves as a consultant to GreenCape Health, a digital health company. He has also received research grants from Amgen, Janssen and CorEvitas.
